PharmAla Biotech Holdings, Inc. (TSE:MDMA)
CNQX:MDMA
Canadian Market
Holding TSE:MDMA?
Track your performance easily

PharmAla Biotech Holdings, Inc. (MDMA) Cash flow

45 Followers

PharmAla Biotech Holdings, Inc. Cash Flow

TSE:MDMA's free cash flow for Q4 2023 was C$-42.20K. For the 2023 fiscal year, TSE:MDMA's free cash flow was decreased by C$773.85K and operating cash flow was C$14.32K. See a summary of the company’s cash flow.
Cash Flow
TTM
Aug 23Aug 22Aug 21
Operating Cash Flow
C$ -318.48KC$ -339.66KC$ -625.37KC$ -173.57K
Investing Cash Flow
C$ -607.95KC$ -506.74KC$ -994.87KC$ 629.22K
Financing Cash Flow
C$ 298.39KC$ 189.29K-C$ 2.02M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
C$ 1.65MC$ 195.04KC$ 852.14KC$ 2.47M
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
----
Issuance Of Capital Stock
C$ 39.10K--C$ 83.44K
Issuance Of Debt
----
Repayment Of Debt
----
Free Cash Flow
C$ -926.43KC$ -846.39KC$ -1.62MC$ -435.76K
Domestic Sales
----
Foreign Sales
----
Currency in CAD

PharmAla Biotech Holdings, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis